PF 04449913
CAS: 1095173-27-5
Rif. 3D-VTB17327
| 5mg | Fuori produzione | ||
| 10mg | Fuori produzione | ||
| 25mg | Fuori produzione | ||
| 50mg | Fuori produzione | ||
| 100mg | Fuori produzione |
Informazioni sul prodotto
Nome:
PF 04449913
Sinonimi:
- 1-((2R,4R)-2-(1H-Benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea
- Glasdegib
- N-[(2R,4R)-2-(1H-Benzimidazol-2-yl)-1-methyl-4-piperidinyl]-N′-(4-cyanophenyl)urea
- Urea, N-[(2R,4R)-2-(1H-benzimidazol-2-yl)-1-methyl-4-piperidinyl]-N′-(4-cyanophenyl)-
Descrizione:
PF 04449913 is a potent inhibitor of the enzyme caspase-3. It has been shown to have long-term efficacy and good tolerability in phase II clinical trials. PF 04449913 interacts with cell factor, a protein that is involved in the regulation of cell growth, differentiation, and apoptosis. This inhibition leads to inhibition of myeloid leukemia cells, which are important for the production of white blood cells and platelets in the body. PF 04449913 also inhibits Toll-like receptor signaling pathways that are activated by microbial products such as lipopolysaccharide (LPS). In vivo models have shown PF 04449913 to be well tolerated at doses up to 150 mg/kg/day and to reduce tumor size in mouse xenografts.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
374.45 g/mol
Formula:
C21H22N6O
Purezza:
Min. 95%
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
